MetLife
- Market cap
- 60.87B
- P/E (TTM)i
- 18.35
- P/Bi
- 2.22
- EPSi
- 4.71
- Div yieldi
- 2.40%
- 52W posi
- 85%
Anonymous reader poll. Unscientific, not investment advice.
MetLife ended the session at 95.78, down 1.42%. Its market capitalisation is about 60.87B, the #367 most valuable US-listed company we track. Trading at a P/E of 18.56, the stock is 10% above its own five-year norm of 16.93. The stock also carries a trailing dividend yield of 2.40%. The 12 analysts covering the stock are, on balance, at Buy, targeting an average of 107.91 (+13%). The shares sit 85% of the way up their 52-week range of 66.41 to 100.93.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 5 months.
- Recent price momentum is +12.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation A-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 18.6x | Better than 52% |
| Forward P/E | 9.8x | Better than 85% |
| Price / Sales | 0.8x | Better than 88% |
| P/E vs own 5-yr range | 64th pctl | Better than 45% |
Growth C
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 3.9% | Better than 38% |
| Net income CAGR (3Y) | -13.8% | Better than 20% |
| Free cash flow CAGR (3Y) | 9.4% | Better than 49% |
Profitability C
How much profit the business keeps from each dollar of sales and capital.
| Net margin | 4.2% | Better than 25% |
| Return on equity | 11.4% | Better than 44% |
Momentum A
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 6.3% | Better than 69% |
| 6-month return | 38.0% | Better than 85% |
| 12-month return (ex latest month) | 21.9% | Better than 58% |
| Distance below 52-week high | 4.0% | Better than 93% |
Financial Health A
Balance-sheet strength: leverage, liquidity and interest coverage.
| Debt to assets | 2.7% | Better than 91% |
| Interest coverage | 5.4x | Better than 44% |
| Free cash flow / net income | 505.8% | Better than 95% |
Analyst View B-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 91.7% | Better than 76% |
| Upside to average target | 11.4% | Better than 19% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 97.16
- Open
- 96.34
- Day range
- 95.42 - 96.82
- Avg price
- 95.90
- Volume
- 3.18M
- Turnover
- 304.57M
- Turnover ratei
- 0.60%
- Volume ratioi
- 0.86
- Amplitudei
- 1.44%
- 52-week rangei
- 66.41 - 100.93
Valuation
- P/Ei
- 20.34
- P/E (TTM)i
- 18.35
- P/Bi
- 2.22
- EPSi
- 4.71
- Book value / shi
- 43.18
- Net profit
- 2.99B
- Net assets
- 27.44B
Share structure
- Market cap
- 60.87B
- Float capi
- 50.88B
- Shares out
- 635.48M
- Float sharesi
- 531.23M
Dividend & listing
- Div yield (TTM)i
- 2.40%
- Dividend (TTM)
- 2.30
- Listing date
- 2000-04-05
5.1% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-217.81M net over the window
Short interest
- Shares short
- 12.29M
- % of floati
- 1.93%
- Days to coveri
- 4.44
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of MetLife (MET)?
MetLife last traded at 95.78. The quote on this page refreshes every few seconds while US markets are open.
What is MetLife's market cap?
About 60.87B.
What is the P/E ratio of MetLife?
The trailing twelve-month P/E is 18.35, above its own 5-year average of 16.93 — in the middle of its historical range (63.37% percentile). See the Valuation tab for the full history.
Does MetLife pay a dividend?
Yes. The trailing dividend yield is 2.40%. The 2025 payout was up 4.3% from 2024. See the Dividends tab for the full payment history.
Is MetLife a buy according to analysts?
The consensus of 12 analysts is a Buy rating, with an average 12-month price target of 107.91, which implies 12.7% upside from the current price. This is not investment advice.
What is MetLife's StockVane Quant Rating?
The StockVane Momentum strategy currently rates MetLife a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-10-08 06:27:24 · For reference only, not investment advice and not tailored to your situation.